Chronic Pulmonary Aspergillosis research hub
4 indexed studies · 1 currently recruiting
- active not recruitingPHASE2
Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study
This study is looking into whether adding a drug called interferon-gamma to usual antifungal treatment can help people with a long-term lung infection called chronic pulmonary aspergillosis (CPA). We want to see if it improves their condition and quality of life.
United Kingdom - recruiting
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
This study aims to create a new questionnaire for people with Chronic Pulmonary Aspergillosis (CPA). This questionnaire will help understand how CPA affects their daily lives and overall well-being, providing a better way to measure their health in future research and trials. Participants must have CPA and be over 18.
United Kingdom - active not recruitingPHASE2
Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options
This study is testing a new weekly drug called rezafungin for adults with a serious lung infection called Chronic Pulmonary Aspergillosis (CPA). It's for people who haven't found other treatments effective or can't take them. We want to see if it's safe and helps improve their health over six months.
Austria · Belgium · France - authorisedHuman Pharmacology (Phase I)- Other
Nebulised lIposomal aMphotericin B in chronic pUlmonary aSpergillosis: a deposition study
This study looks at how much of a medicine called AmBisome, given as a mist you breathe in, reaches the lungs. It aims to find the best dose for treating a fungal lung infection called chronic pulmonary aspergillosis, while also checking for any side effects.
Netherlands